Patient/caregiver was instructed regarding contraindications to receive PPSV23 pneumococcal vaccination as follows: Individuals with life-threatening allergic reaction to previous administration of this vaccine should not receive any further doses of this vaccine. Individuals with life-threatening allergic reaction to any component of this vaccine should not receive any further doses of this vaccine. Children below 2 years of age are contraindicated to receive PPSV23 vaccine.

Patient/caregiver was instructed regarding contraindications to receive PCV13 pneumococcal vaccination as follows: Individuals with life-threatening allergic reaction to previous administration of this vaccine should not receive any further doses of this vaccine. Before PCV13, another pneumococcal vaccine called PCV7 was being administered. PCV7 offered protection against infections caused by 7 different serotypes of pneumococcal bacteria. The protection coverage for pneumococcal vaccine was extended with introduction of PCV13, which offers protection against infections caused by 13 [...]

Patient/caregiver was instructed regarding schedule of pneumococcal vaccinations as follows: PCV13 vaccine administered into the muscle, is usually recommended for children younger than 2 years of age. This vaccine is given to children in 4 doses at 2, 4, 6, and 12 through 15 months of age. This vaccination offers protection against protection against 13 of the approximately 90 types of pneumococcal bacteria causing the most serious types of pneumococcal illnesses in children, such as, [...]

Patient/caregiver was instructed regarding indications to receive PCV13 pneumococcal vaccination as follows: PCV13 vaccine administered into the muscle, is usually recommended for children younger than 2 years of age. This vaccine is given to children in 4 doses at 2, 4, 6, and 12 through 15 months of age. This vaccination offers protection against protection against 13 of the approximately 90 types of pneumococcal bacteria causing the most serious types of pneumococcal illnesses in children, [...]

Patient/caregiver was instructed regarding indications to receive PPSV23 pneumococcal vaccination as follows: PPSV23 vaccine administered into the muscle or beneath the skin, is usually recommended for adults, 65 years and older. offers protection against 23 of the approximately 90 types of pneumococcal bacteria causing the most serious types of pneumococcal illnesses in older adults, such as, pneumonia, meningitis, and bacteremia. Adult individuals, 19-64 years of age with poor immune status and especially those with no [...]